[1]
S. K, I. S. S. Vaz, and R. S, “Comparative Evaluation of Nitrosamine Impurity Control Strategies in USFDA, EMA, and WHO Pharmaceutical Submissions”, Int J Drug Reg Affairs, vol. 14, no. 3, pp. 77-91, Sep. 2026.